广誉远龟龄集品牌怎么样 申请店铺

我要投票 广誉远龟龄集在保健酒行业中的票数:185 更新时间:2025-02-24
广誉远龟龄集是哪个国家的品牌?「广誉远龟龄集」是 山西广誉远国药有限公司 旗下著名品牌。该品牌发源于山西,由创始人张斌在1998-02-25期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力广誉远龟龄集品牌出海!通过在本页面挂载广誉远龟龄集品牌的产品链接和联系邮箱,可以提高广誉远龟龄集产品曝光!跨境电商爆单神器,目前只要100元/年哦~

广誉远龟龄集怎么样

广誉远始创于明嘉靖二十年(公元1541年),距今已有473年的历史,其间历经广盛号药店、广升聚、广升蔚、广升誉、广升远、山西中药厂、山西广誉远等十几个商号药厂更迭。在清代曾与广州陈李济(1600年创建)、北京同仁堂(1669年创建)、杭州胡庆余堂(1874年创建)并称为“四大药店”,现为山西省中药企业典范,并在2006年成为首批被中华人民共和国商务部认定的“中华老字号”企业。

广誉远主导产品“龟龄集”和“定坤丹”,是中华中医药宝库珍藏的养生至宝,是博大精深的中医药文化的智慧结晶,现为国家级保密处方,分别在2008年和2011年被中华人民共和国国务院评为国家级非物质文化遗产。龟龄集、定坤丹,“御用圣品”的宫廷出身,数百年的药用历史,深刻佐证了其功效卓著;多位皇帝的相关御批,真实确凿的史料档案,更显其品味尊贵。包括龟龄集、定坤丹在内,广誉远系列产品荣获众多国际级奖项、国家级荣誉,在国际传统医药界有深远影响。

广誉远拥有丰富的产品服务群,有丸剂、胶囊剂、酒剂、片剂、颗粒剂、散剂、口服液、煎膏剂共八个剂型,继承着龟龄集、定坤丹、安宫牛黄丸、牛黄清心丸、六味地黄丸、乌鸡白凤丸等103种中药古方及炮制工艺,从方剂、配伍、选材、炮制等诸多方面,承载并展现着中华中医药文化的核心精神与巨大价值。

“尊德贵生,传承创新”是广誉远的企业理念,广誉远坚定地以文化为先导,专注于中医药领域,坚持“继承与创新”的发展策略,充分利用企业内部的产品资源,通过持续的品牌建设和创新营销,走出“特色”道路,努力打造“人无我有,人有我优,做中国最具特色的国药”之企业形象,并在未来五年内,推出精品中药“百家千店”工程,在全国范围内建立100家国医馆、1000家国药堂,包括人参、鹿茸、枸杞、西红花、地黄、肉苁蓉、参等九大GAP养植基地。

473年来,广誉远严苛制药,精益求精,秉承“修合虽无人见,存心自有天知”的古训,遵循“非义而为,一介不取;合情之道,九百何辞”的准则,恪守诚信自律的晋商精神,以信誉为根本,“以义制利”铸就了百年老店的历久弥新。

2003年,由全国著名的大型现代化医药企业——西安东盛集团投资控股,结合现代管理运营理念,将广誉远传统老店,发展成为集中成药研发、生产、销售于一体的高科技现代化制药企业。在国家“十二五规划”对中医药行业的明确指导下,在祖国全面建设小康社会的新时期,在中华民族伟大复兴的历史时刻,广誉远以精品养生中药回馈社会大众,开创智慧养生的新纪元。广誉远作为中国非物质文化遗产的传承者,将为振兴传统中医药文化,贡献应尽的社会责任与历史使命,树立起中医药文化的全新价值。

Guangyuyuan was founded in the 20th year of Jiajing, Ming Dynasty (1541 A.D.), which has a history of 473 years. During this period, guangyuyuan has experienced the change of more than ten famous pharmaceutical companies, such as Guangsheng drugstore, guangshengju, guangshengwei, guangshengyu, guangshengyuan, Shanxi Traditional Chinese medicine factory and Shanxi guangyuyuan. In the Qing Dynasty, it was named as "four drugstores" together with Chen Liji in Guangzhou (founded in 1600), Tongrentang in Beijing (founded in 1669) and Hu qingyutang in Hangzhou (founded in 1874). It is now a model of traditional Chinese medicine enterprises in Shanxi Province, and became one of the first batch of "old Chinese brand" enterprises recognized by the Ministry of Commerce of the people's Republic of China in 2006. Guangyuyuan's leading products "Guilingji" and "dingkundan" are the treasure of health preservation in the treasure house of traditional Chinese medicine, and the wisdom crystallization of extensive and profound traditional Chinese medicine culture. They are now state-level secret prescriptions, and were rated as national intangible cultural heritage by the State Council of the people's Republic of China in 2008 and 2011 respectively. Guilingji, dingkundan, the Royal origin of "imperial holy product", and hundreds of years of medicinal history, have proved its remarkable efficacy; the relevant imperial approvals of several emperors, authentic historical data files, show its taste and dignity. Including Guilingji and dingkundan, guangyuyuan series products have won many international and national awards, and have a profound influence in the international traditional medicine industry. Guangyuyuan has a wealth of product service groups, including eight dosage forms of pills, capsules, liquors, tablets, granules, powders, oral liquids and decoctions. It inherits 103 traditional Chinese medicine prescriptions and processing technologies, including Guilingji, dingkundan, Angongniuhuang, Niuhuang Qingxin, Liuwei Dihuang, Wuji Baifeng, etc., and carries and manufactures from many aspects, such as prescriptions, compatibility, material selection and processing It shows the core spirit and great value of Chinese traditional medicine culture. "Respecting morality, valuing health, inheriting innovation" is guangyuyuan ' In the next five years, we will launch the project of "one hundred thousand stores" of high-quality traditional Chinese medicine, and set up 100 national medicine halls and 1000 national medicine halls nationwide, including nine GAP cultivation bases including ginseng, antler, Lycium, crocus, rehmannia, Cistanche deserticola and ginseng. In the past 473 years, guangyuyuan has been strict in pharmaceutical industry, striving for perfection, adhering to the ancient motto of "no one can see the mending, no one can take it; the way to be reasonable, nine hundred words", abiding by the spirit of integrity and self-discipline of Shanxi merchants, taking reputation as the foundation, and "making profits by righteousness" has made the century old shop new for a long time. In 2003, Xi'an Dongsheng Group, a famous modern pharmaceutical enterprise in China, invested and held the shares, combined with the modern management and operation concept, and developed guangyuyuan traditional old store into a high-tech modern pharmaceutical enterprise integrating the research and development, production and sales of patent medicine. Under the clear guidance of the 12th Five Year Plan for the industry of traditional Chinese medicine, in the new era of building a well-off society in an all-round way in the motherland, and at the historical moment of the great rejuvenation of the Chinese nation, it is well-known for giving back to the public with high-quality health care traditional Chinese medicine and creating a new era of intelligent health care. Guangyuyuan, as the inheritor of Chinese intangible cultural heritage, will contribute to the revitalization of traditional Chinese medicine culture, social responsibility and historical mission, and establish a new value of Chinese medicine culture.

本文链接: https://brand.waitui.com/90f4e668b.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

一汽大众ID.系列部分车型官降至高5.5万元

一汽-大众宣布对旗下ID.系列部分车型进行降价,最高降幅达5.5万元。此次降价活动涉及ID.4 CROZZ和ID.6 CROZZ两款车型,无门槛一口价分别为13.99万元和19.59万元起,还可叠加官方置换补贴至高1万元、国家置换补贴至高2万元。(财联社)

2小时前

2025年中央一号文件发布

36氪获悉,2025年中央一号文件2月23日发布,《中共中央 国务院关于进一步深化农村改革 扎实推进乡村全面振兴的意见》提出,以改革开放和科技创新为动力,巩固和完善农村基本经营制度,深入学习运用“千万工程”经验,确保国家粮食安全,确保不发生规模性返贫致贫,提升乡村产业发展水平、乡村建设水平、乡村治理水平,千方百计推动农业增效益、农村增活力、农民增收入,为推进中国式现代化提供基础支撑,这是党的十八大以来第13个指导“三农”工作的中央一号文件。

2小时前

海天味业:公司发行H股备案申请材料获中国证监会接收

36氪获悉,海天味业公告称,公司已于2025年1月13日向香港联交所递交了发行H股股票并在香港联交所主板挂牌上市的申请。公司已向中国证监会报送了关于公司本次发行的备案申请材料并于近日获中国证监会接收。该事项仍存在不确定性,公司将根据进展情况及时履行信息披露义务。

2小时前

山河药辅:股东复星医药拟减持不超过3%公司股份

36氪获悉,山河药辅发布公告,股东上海复星医药产业发展有限公司因经营需要,计划以集中竞价和大宗交易方式合计减持公司股份不超过697.8万股,即不超过公司总股本的3%。

2小时前

镁伽科技正式推出LABILLION™实验室智慧管理平台,并于线上发布

36氪获悉,近日镁伽科技正式推出LABILLION™实验室智慧管理平台,并于线上发布。作为镁伽在“AI for Science(AI4S)”领域的新成果,LABILLION™以AI与自动化技术为核心,针对生命科学研发中长期存在的数据孤岛、系统僵化、流程低效等痛点,为科学家提供从实验设计到数据分析的全链路智能支持,助力科研创新效率的提升。

2小时前

本页详细列出关于鸿茅药酒的品牌信息,含品牌所属公司介绍,鸿茅药酒所处行业的品牌地位及优势。
咨询